Alpa Laboratories (NSE:ALPA) Total Receivables: ₹414 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ALPA Alpa Laboratories Ltd NSE:ALPA
77 GF Score
Price ₹68.91
GF Value ₹92.95
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Alpa Laboratories Total Receivables?

Alpa Laboratories NSE:ALPA +0.97% 77 Total Receivables is ₹414 Mil as of Mar. 2026. GuruFocus rates NSE:ALPA with a GF Score™ of 77/100 and a GF Value™ of ₹92.95 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Alpa Laboratories's Total Receivables for the quarter that ended in Mar. 2026 was ₹414 Mil.

Alpa Laboratories Total Receivables Related Terms

Alpa Laboratories Total Receivables Historical Data

* Premium members only.

The historical data trend for Alpa Laboratories's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpa Laboratories Total Receivables Chart

Alpa Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 448.11 489.76 435.02 502.10 413.61

Alpa Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 502.10 0.00 372.89 0.00 413.61
NSE:ALPA
77GF Score
Alpa Laboratories Ltd NSE:ALPA
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpa Laboratories Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of ₹414 Mil mean?
Alpa Laboratories (NSE:ALPA) has a Total Receivables of ₹414 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Alpa Laboratories and its competitors.
Is Alpa Laboratories' Total Receivables too high?
Alpa Laboratories' current Total Receivables is ₹414 Mil. Overall, Alpa Laboratories has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alpa Laboratories' Total Receivables compare to ZTS and UTHR?
Alpa Laboratories' Total Receivables of ₹414 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Alpa Laboratories and its competitors. Alpa Laboratories's current Total Receivables is ₹414 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Alpa Laboratories (NSE:ALPA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹92.95, compared to a current price of ₹68.91 — trading 25.9% below its estimated fair value. The current Total Receivables is ₹414 Mil. Alpa Laboratories' overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Alpa Laboratories (NSE:ALPA), the current Total Receivables is ₹414 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alpa Laboratories (NSE:ALPA) Overvalued in 2026?

Based on GuruFocus' analysis, Alpa Laboratories stock appears to be undervalued. The current stock price of ₹68.91 is trading 25.9% below its estimated GF Value™ of ₹92.95. GuruFocus considers Alpa Laboratories to be Modestly Undervalued.

Key valuation signals for NSE:ALPA:

  • Total Receivables: ₹414 Mil
  • GF Value™: ₹92.95 vs. price of ₹68.91 (25.9% below fair value)
  • GF Score™: 77/100 with 5 warning signs

No single metric tells the full story. See the NSE:ALPA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alpa Laboratories Business Description

Other Exchanges 532878:India
Address 33/2, A.B. Road, Pigdamber, Rau, Indore, MP, IND, 453446
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the drug and chemical business segment. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.
77GF Score

Get the complete analysis for NSE:ALPA

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹68.91
Price
₹92.95
GF Value